TABLE OF CONTENTS
| | | | Volume 8 (May 2018) | | In this issue Article Current Treatment Algorithm Correspondence | | | | | | | | | Article | | | Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Dimitrios Christoulas, Tina Bagratuni, Marios Bakogeorgos et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0075-6 Abstract | Full Text | | Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study Kenshi Suzuki, Meletios A. Dimopoulos, Naoki Takezako, Shinichiro Okamoto, Atsushi Shinagawa et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0071-x Abstract | Full Text | | Current Treatment Algorithm | | | Myelodysplastic syndromes current treatment algorithm 2018 David P. Steensma Blood Cancer Journal 2018 8: 10.1038/s41408-018-0085-4 Abstract | Full Text | | Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018 Morie A. Gertz Blood Cancer Journal 2018 8: 10.1038/s41408-018-0080-9 Abstract | Full Text | | Waldenström macroglobulinemia treatment algorithm 2018 Morie A. Gertz Blood Cancer Journal 2018 8: 10.1038/s41408-018-0076-5 Abstract | Full Text | | Correspondence | | | The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition Shira Kahlon, Dorin Shreibman, Tamar Unger, Dina Ben-Yehuda & Shlomo Elias Blood Cancer Journal 2018 8: 10.1038/s41408-018-0082-7 Abstract | Full Text | | Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis Efstathios Kastritis, Ioannis V. Kostopoulos, Evangelos Terpos, Bruno Paiva, Despina Fotiou et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0086-3 Abstract | Full Text | | RTK-RAS pathway mutation is enriched in myeloid sarcoma Mihong Choi, Yoon Kyung Jeon, Choong-Hyun Sun, Hong-Seok Yun, Junshik Hong et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0083-6 Abstract | Full Text | | Monitoring of asparagine depletion and anti-l-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial Jérôme Paillassa, Thibaut Leguay, Xavier Thomas, Françoise Huguet, Marie Audrain et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0084-5 Abstract | Full Text | | | | | | Advertisement | | Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. | | | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | | |
No comments:
Post a Comment